Key statistics
As of last trade Revvity Inc (PKN:FRA) traded at 105.85, -9.95% below its 52-week high of 117.55, set on Nov 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 105.10 |
---|---|
High | 105.85 |
Low | 105.10 |
Bid | 106.70 |
Offer | 108.90 |
Previous close | 106.15 |
Average volume | 179.33 |
---|---|
Shares outstanding | 121.70m |
Free float | 121.35m |
P/E (TTM) | 53.04 |
Market cap | 13.52bn USD |
EPS (TTM) | 2.09 USD |
Annual div (ADY) | 0.2673 EUR |
---|---|
Annual div yield (ADY) | 0.25% |
Div ex-date | Oct 18 2024 |
Div pay-date | Nov 08 2024 |
Next div ex-date | Jan 17 2025 |
Next div pay-date | Feb 07 2025 |
Data delayed at least 15 minutes, as of Nov 22 2024 15:39 GMT.
More ▼
Press releases
- Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK
- Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference
- Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells
- Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation
- Revvity Announces Financial Results for the Third Quarter of 2024
- Revvity Board Declares Quarterly Dividend
- Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories
- Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report
- Revvity To Hold Earnings Call on Monday, November 4, 2024
- Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene
More ▼